openPR Logo

Press Releases from Bayerische Patentallianz GmbH (1 total)

European Patent granted for XL-protein’s PASylation® technology

XL-protein GmbH, a German biotech company that specialises in the development of biopharmaceuticals with extended plasma half-life, today announced that the European Patent Office granted a core patent (EP2173890) for XL-protein’s PASylation® technology. In 2009, XL-protein entered into a license agreement with TUM via Bayerische Patentallianz GmbH, the central patent and marketing agency for 28 Bavarian universities and universities of applied sciences, and acquired the exclusive worldwide rights for the

Go To Page:   1 2 3 4 5 6 7 8 9 10